InVision Medical Technology Corporation

InVision Medical Technology Corporation has 2 AI-enabled medical devices on the FDA list. The first decision was on April 25, 2024 and the most recent on May 21, 2025 (InVision Precision Cardiac Amyloid). Its most common review panel is Cardiovascular (1 device).